Decoy Therapeutics (DCOY) Net Equity Issued and Repurchased (2018 - 2020)
Decoy Therapeutics (DCOY) posted quarterly Net Equity Issued and Repurchased of $9.9 million for Q1 2020, up 554.15% year-over-year from $1.5 million in Q2 2019, and up 276.18% quarter-over-quarter from $2.6 million in Q4 2019.
Decoy Therapeutics (DCOY) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $9.9 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Net Equity Issued and Repurchased rose 554.15% year-over-year to $9.9 million; the TTM figure through Mar 2020 stood at $14.0 million (up 842.0% YoY), while the FY2019 annual figure was $4.1 million, up 103.96% from the prior year.
- Net Equity Issued and Repurchased advanced to $9.9 million in Q1 2020 per DCOY's latest filing, from $2.6 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.9 million in Q1 2020 and bottomed at -$25000.0 in Q4 2018.
- Historically, Net Equity Issued and Repurchased has averaged $3.5 million across 3 years, with a median of $2.1 million in 2019.
- Annual changes were most pronounced in 2019 — Net Equity Issued and Repurchased jumped 10590.43% — and 2020, when it soared 554.15%.
- Decoy Therapeutics' Net Equity Issued and Repurchased stood at -$25000.0 in 2018, then surged by 10590.43% to $2.6 million in 2019, then soared by 276.18% to $9.9 million in 2020.
- Business Quant data shows DCOY's Net Equity Issued and Repurchased at $9.9 million in Q1 2020, $2.6 million in Q4 2019, and $1.5 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 9.87 Mn |
| Mar 31, 2020 | 9.87 Mn |
| Dec 31, 2019 | 2.62 Mn |
| Dec 31, 2019 | 2.62 Mn |
| Mar 31, 2019 | 1.51 Mn |
| Mar 31, 2019 | 1.51 Mn |
| Dec 31, 2018 | -25,000.00 |
| Dec 31, 2018 | -25,000.00 |